0001439222-22-000051.txt : 20220524 0001439222-22-000051.hdr.sgml : 20220524 20220524161149 ACCESSION NUMBER: 0001439222-22-000051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220520 FILED AS OF DATE: 20220524 DATE AS OF CHANGE: 20220524 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schenkein David P CENTRAL INDEX KEY: 0001578200 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 22956758 MAIL ADDRESS: STREET 1: C/O BLUEBIRD BIO, INC. STREET 2: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-8600 MAIL ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AGIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20080703 4 1 wf-form4_165342307618924.xml FORM 4 X0306 4 2022-05-20 0 0001439222 AGIOS PHARMACEUTICALS, INC. AGIO 0001578200 Schenkein David P C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139 1 0 0 0 Common stock 2022-05-20 4 M 0 1585 0 A 117879 D Common stock 79082 I See footnote Common stock 270772 I See footnote Restricted stock unit 2022-05-20 4 M 0 1585 0 D Common stock 1585.0 0 D Shares held by Amy P. Schenkein 2004 Revocable Trust, of which the reporting person's spouse is trustee and beneficiary. Shares held by David P. Schenkein 2004 Revocable Trust, of which the reporting person is trustee and beneficiary. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. There restricted stock units were granted on May 20, 2021. The shares underlying these restricted stock units vest as to 100% of the underlying shares on May 20, 2022. /s/ William Cook, as Attorney in Fact for David Schenkein 2022-05-24